Patients with major depressive disorder and patients with inflammatory skin diseases like atopic dermatitis share similar ...

You spot signs of depression in someone you care about or in yourself and want a clear explanation. Research still shows no ...

Compared with usual care, use of the PETRUSHKA tool increased the number of patients still taking their antidepressant at 8 weeks and improved depressive and anxiety symptoms at 24 weeks. However, ...

Dr.: There are well-established therapies that can help those afflicted with SAD to get through the dark winter months ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Depression is a complex and deeply personal experience. While almost everyone has periods of sadness, low mood or grief, depression is different. Major depressive disorder is persistent, interferes ...

Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...

Treatment with the psychedelic dimethyltryptamine, or DMT, alongside psychotherapy, can relieve severe depressive symptoms, a phase 2 trial has found.

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

This study suggests is that clinicians "may be able to offer patients a path to meaningful relief in less than 1 week." ...